BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 2404046)

  • 1. Implications of preoperative administration of aspirin in patients undergoing coronary artery bypass grafting. Department of Veterans Affairs Cooperative Study on Antiplatelet Therapy.
    Sethi GK; Copeland JG; Goldman S; Moritz T; Zadina K; Henderson WG
    J Am Coll Cardiol; 1990 Jan; 15(1):15-20. PubMed ID: 2404046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study.
    Goldman S; Copeland J; Moritz T; Henderson W; Zadina K; Ovitt T; Doherty J; Read R; Chesler E; Sako Y
    Circulation; 1988 Jun; 77(6):1324-32. PubMed ID: 3286040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study.
    Goldman S; Copeland J; Moritz T; Henderson W; Zadina K; Ovitt T; Doherty J; Read R; Chesler E; Sako Y
    Circulation; 1989 Nov; 80(5):1190-7. PubMed ID: 2680158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of low dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: patency and clinical outcome at 1 year. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. Prevention of Coronary Artery Bypass Graft Occlusion by Aspirin, Dipyridamole and Acenocoumarol/Phenprocoumon Study.
    van der Meer J; Brutel de la Rivière A; van Gilst WH; Hillege HL; Pfisterer M; Kootstra GJ; Dunselman PH; Mulder BJ; Lie KI
    J Am Coll Cardiol; 1994 Nov; 24(5):1181-8. PubMed ID: 7930237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy outcomes of preoperative aspirin in patients undergoing coronary artery bypass grafting: a systematic review and meta-analysis.
    Ma X; Ma C; Yun Y; Zhang Q; Zheng X
    J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):97-113. PubMed ID: 24212980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Starting aspirin therapy after operation. Effects on early graft patency. Department of Veterans Affairs Cooperative Study Group.
    Goldman S; Copeland J; Moritz T; Henderson W; Zadina K; Ovitt T; Kern KB; Sethi G; Sharma GV; Khuri S
    Circulation; 1991 Aug; 84(2):520-6. PubMed ID: 1860197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of antiplatelet therapy with indobufen or aspirin-dipyridamole on graft patency one year after coronary artery bypass grafting.
    Rajah SM; Nair U; Rees M; Saunders N; Walker D; Williams G; Critchley A; Beton D; Campbell C; Lawson RA
    J Thorac Cardiovasc Surg; 1994 Apr; 107(4):1146-53. PubMed ID: 8159037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of anticoagulant therapy started pre-operatively in preventing coronary vein graft occlusion.
    Yli-Mäyry S; Huikuri HV; Korhonen UR; Airaksinen KE; Ikäheimo MJ; Linnaluoto MK; Takkunen JT
    Eur Heart J; 1992 Sep; 13(9):1259-64. PubMed ID: 1396838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immediate postoperative aspirin improves vein graft patency early and late after coronary artery bypass graft surgery. A placebo-controlled, randomized study.
    Gavaghan TP; Gebski V; Baron DW
    Circulation; 1991 May; 83(5):1526-33. PubMed ID: 2022014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of early aortocoronary bypass occlusion by low-dose aspirin and dipyridamole. Grupo Español para el Seguimiento del Injerto Coronario (GESIC).
    Sanz G; Pajarón A; Alegría E; Coello I; Cardona M; Fournier JA; Gómez-Recio M; Ruano J; Hidalgo R; Medina A
    Circulation; 1990 Sep; 82(3):765-73. PubMed ID: 2203555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of one-year vein-graft occlusion after aortocoronary-bypass surgery: a comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants. The CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands.
    van der Meer J; Hillege HL; Kootstra GJ; Ascoop CA; Mulder BJ; Pfisterer M; van Gilst WH; Lie KI
    Lancet; 1993 Jul; 342(8866):257-64. PubMed ID: 8101300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the impact of preoperative aspirin administration on patients undergoing coronary artery bypass grafting?
    Aboul-Hassan SS; Stankowski T; Marczak J; Cichon R
    Interact Cardiovasc Thorac Surg; 2017 Feb; 24(2):280-285. PubMed ID: 27702830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin plus clopidogrel therapy increases early venous graft patency after coronary artery bypass surgery a single-center, randomized, controlled trial.
    Gao G; Zheng Z; Pi Y; Lu B; Lu J; Hu S
    J Am Coll Cardiol; 2010 Nov; 56(20):1639-43. PubMed ID: 21050973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of dipyridamole and aspirin on vein graft patency after coronary bypass operations.
    Chesebro JH
    Thromb Res Suppl; 1990; 12():5-10. PubMed ID: 2082487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ticagrelor and aspirin for the prevention of cardiovascular events after coronary artery bypass graft surgery.
    Saw J; Wong GC; Mayo J; Bernstein V; Mancini GB; Ye J; Skarsgard P; Starovoytov A; Cairns J
    Heart; 2016 May; 102(10):763-9. PubMed ID: 26891756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised placebo controlled trial of aspirin and dipyridamole in the prevention of coronary vein graft occlusion.
    Brooks N; Wright J; Sturridge M; Pepper J; Magee P; Walesby R; Layton C; Honey M; Balcon R
    Br Heart J; 1985 Feb; 53(2):201-7. PubMed ID: 3881108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of aspirin and clopidogrel versus aspirin alone for the prevention of coronary artery bypass graft occlusion: the Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting study.
    Sun JC; Teoh KH; Lamy A; Sheth T; Ellins ML; Jung H; Yusuf S; Anand S; Connolly S; Whitlock RP; Eikelboom JW
    Am Heart J; 2010 Dec; 160(6):1178-84. PubMed ID: 21146675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis and prevention of aortocoronary bypass graft occlusion.
    Chesebro JH; Fuster V
    Int J Clin Pharmacol Res; 1986; 6(4):261-7. PubMed ID: 3531036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylsalicylic acid and dipyridamole improve the early patency of aorta-coronary bypass grafts. A double-blind, placebo-controlled, randomized trial.
    Rajah SM; Salter MC; Donaldson DR; Subba Rao R; Boyle RM; Partridge JB; Watson DA
    J Thorac Cardiovasc Surg; 1985 Sep; 90(3):373-7. PubMed ID: 3897722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts.
    Stein PD; Dalen JE; Goldman S; Théroux P
    Chest; 1998 Nov; 114(5 Suppl):658S-665S. PubMed ID: 9822069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.